These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 3096861)

  • 1. Trifluoperazine inhibits thyrotropin-releasing hormone-stimulated TSH secretion.
    Zofková I; BednárJ
    Horm Metab Res; 1986 Sep; 18(9):621-4. PubMed ID: 3096861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 1.25 (OH)2 vitamin D3 (calcitriol) on TRH-induced thyrotropin secretion in man.
    Zofková I; Bednár J
    Exp Clin Endocrinol; 1988 Mar; 91(1):7-12. PubMed ID: 3131152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcitonin inhibits TRH-induced TSH secretion.
    Zofková I; Bednár J
    Exp Clin Endocrinol; 1984 May; 83(3):263-8. PubMed ID: 6432564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcitonin, 1,25(OH)2 vitamin D3 and trifluoperazine on thyrotropic secretion and their mutual interactions.
    Zofková I; Bednár J
    Exp Clin Endocrinol; 1988 Mar; 92(3):268-74. PubMed ID: 3150956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of pyridostigmine and naloxone on the abnormal TSH response to TRH during starvation in humans.
    Coiro V; Volpi R; Capretti L; Caffarri G; Colla R; Chiodera P
    J Investig Med; 1999 May; 47(5):227-31. PubMed ID: 10361382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of pyridostigmine on the thyroid-stimulating hormone response to thyrotropin-releasing hormone in abstinent alcoholics.
    Coiro V; Vescovi PP
    Alcohol Clin Exp Res; 1997 Oct; 21(7):1308-11. PubMed ID: 9347094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic and cholinergic involvement in the inhibitory effect of dexamethasone on the TSH response to TRH.
    Coiro V; Volpi R; Cataldo S; Capretti L; Caffarri G; Pilla S; Chiodera P
    J Investig Med; 2000 Mar; 48(2):133-6. PubMed ID: 10736973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia influences TRH-stimulated TSH and T3 response.
    Zofková I; Blahos J; Bednár J
    Endokrinologie; 1981 Dec; 78(2-3):186-90. PubMed ID: 6800777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thyrotropin responses to synthetic thyrotropin-releasing hormone in normal children and hypopituitary patients. A new test to distinguish primary releasing hormone deficiency from primary pituitary hormone deficiency.
    Foley TP; Owings J; Hayford JT; Blizzard RM
    J Clin Invest; 1972 Feb; 51(2):431-7. PubMed ID: 4621544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of thyrotropin-releasing hormone at weekly intervals results in a diminished thyrotropin response.
    Winokur A; Caroff SN; Amsterdam JD; Maislin G
    Biol Psychiatry; 1984 May; 19(5):695-702. PubMed ID: 6428472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum concentrations of thyroxine and 3,5,3'-triiodothyronine in dogs before and after administration of freshly reconstituted or previously frozen thyrotropin-releasing hormone.
    Rosychuk RA; Freshman JL; Olson PN; Olson JD; Husted PW; Crowder-Sousa ME
    Am J Vet Res; 1988 Oct; 49(10):1722-5. PubMed ID: 3142321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central hypothyroidism--various types of TSH responses to TRH stimulation.
    Trejbal D; Sulla I; Trejbalová L; Lazúrová I; Schwartz P; Machánová Y
    Endocr Regul; 1994 Mar; 28(1):35-40. PubMed ID: 7949012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum calcium decline after intravenous administration of thyrotropin-releasing hormone in man.
    Röjdmark S; Andersson DE; Edström E; Lamminpää K
    Horm Metab Res; 1983 Jun; 15(6):290-3. PubMed ID: 6409774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between TRH-stimulated TSH and basal TSH measurement by a commercial immunoradiometric assay in the management of thyroid disease.
    De Rosa G; Testa A; Giacomini D; Carrozza C; Maussier ML; Valenza V; D'Errico GF
    Q J Nucl Med; 1996 Jun; 40(2):182-7. PubMed ID: 8909104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable thyrotropin response to thyrotropin-releasing hormone after small decreases in plasma free thyroid hormone concentrations in patients with nonthyroidal diseases.
    Maturlo SJ; Rosenbaum RL; Pan C; Surks MI
    J Clin Invest; 1980 Sep; 66(3):451-6. PubMed ID: 6772675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 1,25-dihydroxyvitamin D3 (calcitriol) on prolactin secretion at rest and TRH-stimulated secretion in humans.
    Zofková I; Nedvídková J
    Exp Clin Endocrinol; 1988 May; 91(2):207-11. PubMed ID: 3137083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyrotropin secretion in patients with hyperparathyroidism or hypoparathyroidism: effect of serum calcium on thyrotropin release.
    Hiramatsu K; Hashizume K; Aizawa T; Ichikawa K; Yamada T
    J Clin Endocrinol Metab; 1983 Mar; 56(3):623-6. PubMed ID: 6401763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of metoclopramide on calcium inhibition of thyrotropin response to thyrotropin-releasing hormone.
    Röjdmark S; Andersson DE
    J Clin Endocrinol Metab; 1982 May; 54(5):998-1001. PubMed ID: 6801079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.